NFX88 Phases

Clinical Trial – Phase I

In this phase, the safety of the new drug is verified, involving people for the first time. Side effects, tolerance, method of administration, and safe dosing are evaluated, among other things, based on their actions in the human body.

Clinical Trial – Phase IIA

Phase IIA is used for pilot studies designed to demonstrate clinical efficacy or biological activity.

This phase helps us verify the safety level of our drug, find the optimal treatment dose, and establish preliminary data on its efficacy.

Clinical Trial – Phase IIB

Thanks to Phase IIB, we are able to verify the treatment’s efficacy considering a larger amount of data, thus achieving a higher level of safety.

Clinical Trial – Phase III

In Phase III, safety and efficacy data are verified in a larger sample size. With positive results, regulatory authorities may approve its commercialization.

NFX88 Phases

Clinical Trial – Phase I

Clinical Trial – Phase IIA

Clinical Trial – Phase IIB

Clinical Trial – Phase III

Phases for the launch of a new drug

NEUROFIX INVERSORES

NEUROFIX COMPAÑÍA

ACTUALIDAD NEUROFIX

NEUROFIX CONTACT